Fulcrum Therapeutics Inc.

05/12/2021 | Press release | Distributed by Public on 05/12/2021 05:05

Fulcrum Therapeutics Announces U.S. Food and Drug Administration Grants Fast Track Designation to Losmapimod for the Potential Treatment of Facioscapulohumeral Muscular[...]